He developed LaminarPace specifically to generate small amounts of micronized particle material for aerosolization, originally micronizing particles down to 1 – 5 microns. Consequently, the system delivered dried, thermostable particles that were well dispersed, with excellent size distribution, producing powders that are fast-dissolving and well-suited to inhaled and novel administration routes.
The many high-potential areas LaminarPace ambient drying could be applied to soon became clear. For that reason, Inhalation Sciences carried out a spin-out of LaminarPace into a subsidiary, Ziccum AB, which since mid-2017 has been developing and commercializing the technology on its own.
Explore Ziccum's Business Model and Project portfolio